Navigation Links
Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Date:10/1/2009

industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.

    Investor Relations Contact:
    Kevin McGrath / Cameron Associates, Inc.
    212-245-4577
    Kevin@cameronassoc.com

    MISONIX, INC. And Subsidiaries
    Consolidated Balance Sheets
    Derived from Audited Financial Statements

                                              June 30, 2009  June 30, 2008
                                              -------------  -------------
    Assets
    ------
    Current Assets:
      Cash                                       $3,691,022     $1,873,863
      Accounts receivable, less allowance
       for doubtful accounts of
       $440,077 and $376,998, respectively        8,658,560      7,986,802
      Inventories, net                            6,627,316     11,906,091
      Deferred income taxes                       1,235,902      1,562,279
      Prepaid expenses and other current
       assets                                     1,174,106        904,737
      Assets of discontinued operations                   0        745,473
                                                    -------        -------
    Total current assets                         21,386,906     24,979,245

    Property, plant and equipment, net            5,546,694      4,371,373
    Deferred income taxes                         1,299,388      
'/>"/>
SOURCE  Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Naurex Inc., a new clinical stage company developing ... based on its novel GFPA NMDA receptor modulators, ... I clinical trial of its lead compound GLYX-13 ... the study. GLYX-13, a glycine site functional ... receptor, is initially being developed as a therapy ...
(Date:12/16/2009)... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ... 3 registration clinical trial for KRX-0401 (perifosine), ... / refractory multiple myeloma patients. ,, The ... to Assess the Efficacy and Safety of ... (Velcade®) and Dexamethasone in Multiple Myeloma Patients ...
(Date:12/15/2009)... Ireland, Dec. 15 Warner Chilcott plc ... subsidiary Warner Chilcott Corporation (the "Company") has commenced ... subject to the conditions set forth in the ... dated December 15, 2009 (the "Offer to Purchase"), ... senior subordinated notes due 2015 (the "Notes"). ,, ...
Breaking Medicine Technology:Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Scientists closer to making implantable bone material thanks to new research 9358 1Scientists closer to making implantable bone material thanks to new research 9358 2Assara Laser Hair Removal Centers 28New York NY 29 Receives 2008 New York Award for Cosmetology 26amp 3B Personal Hygiene Salons by the U S C A 52713 1Assara Laser Hair Removal Centers 28New York NY 29 Receives 2008 New York Award for Cosmetology 26amp 3B Personal Hygiene Salons by the U S C A 52713 2SpeechEasy Seeks Proposals For Future Research Studies 52708 1SpeechEasy Seeks Proposals For Future Research Studies 52708 2SpeechEasy Seeks Proposals For Future Research Studies 52708 3
... CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2007 - Elixir,Pharmaceuticals, ... sets,of preclinical data demonstrating that ghrelin antagonism ... of a range of metabolic,disorders. These data ... decreasing body weight, improvements in,blood glucose and ...
... highly potent DPP-4 inhibitor, possessing Ki of 27,pM, ... a privately held drug discovery biopharmaceutical company,announced today ... presented at the 67th session of the American ... that,ARI-2243 is an extremely long acting, potent inhibitor ...
Other Medicine Technology:Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 2Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 3Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 4Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 2Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 3Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 4
(Date:12/16/2009)... site visitors can earn a free 21-count one week trial bottle ... ... Orion, MI (PRWEB) December 16, 2009 -- ImmuneResponse247.com ... Trial Sample” of Immune Response 247™ 6 Mushroom Formula , ... Medicinals, Immune Response 247™ 6 Mushroom Formula is packaged in FDA ...
(Date:12/16/2009)... Request A Test, Ltd. is proud to announce being presented with ... Weatherhead 100 showcases the fastest growing companies in Northeast Ohio and ... to succeed. , ... (PRWEB) December ... being presented with the Weatherhead 100 Upstart Award on December 3, ...
(Date:12/16/2009)... approaching and what would be the perfect gift to give that ... Celebrity Beauty Engineer® and Licensed Esthetician Mary Schook introduces exceptional beauty ... feel their best! , ... (PRWEB) December 16, 2009 ... does a person get that special woman who has everything? Why ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate today rejected an ... Act that would have helped make prescription drugs ... legal importation of lower priced drugs from abroad. ... by Senators Dorgan, Snowe, McCain, Grassley and Stabenow, ... down the skyrocketing costs of prescription drugs. ,, ...
(Date:12/15/2009)... coal for lying about taxes in the healthcare bill ... has earned a place under the "Naughty" column on Americans ... after being caught telling a brazen lie on the floor ... bill would not raise taxes. ,, Speaking on the ... " I have also heard it ...
Breaking Medicine News(10 mins):Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3
... and the University of Pennsylvania have been able to ... Celebrex and Vioxx, administered for treatment// of pain and ... heart problem ,Co-author Colin Funk, a professor of ... in Molecular, Cellular and Physiological Medicine has expressed optimism ...
... Ear Hospital in East Melbourne, Australia says that simple corneal ... so might actually slow healing and does not reduce pain, ... ,“The abrasions on the eye normally don’t affect vision too ... if there is no good reason to do so,” Turner ...
... elderly people turn to God as they approach death. This ... their earlier days.// The study, which appears in the March ... may actually increase the fear of dying in such people. ... hospice patients in North Central Florida all of who were ...
... According to a Pakistani local newspaper three persons with a ... Institute of Medical Sciences (PIMS). //The patients are currently under ... virus. ,According to The News, 22-year-old Syed Wali, his ... brought to the PIMS following manifestation of symptoms of bird ...
... new study by Northeastern University professor Debra L. Franko white ... continue feeling the same.// ,More than two thousand ... the conclusion by the researchers was that the depression rate ... in their African-American counterparts. The study was published in a ...
... your child is getting too little calcium, think twice as ... and calcium-fortified foods that builds stronger bones.// ,"The review ... has little benefit for bone health," said lead author Tania ... as a public health policy for healthy children, the review ...
Other Medicine News:Health News:Calcium Supplements May Not Be Of Much Use For Healthy Kids 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: